Skip to main content
Top
Published in: Malaria Journal 1/2005

Open Access 01-12-2005 | Research

Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya

Authors: Vandana Thathy, JoAnn M Moulds, Bernard Guyah, Walter Otieno, José A Stoute

Published in: Malaria Journal | Issue 1/2005

Login to get access

Abstract

Background

It has been hypothesized that the African alleles Sl2 and McC b of the Swain-Langley (Sl) and McCoy (McC) blood group antigens of the complement receptor 1 (CR1) may confer a survival advantage in the setting of Plasmodium falciparum malaria, but this has not been demonstrated.

Methods

To test this hypothesis, children in western Kenya with severe malaria-associated anaemia or cerebral malaria were matched to symptomatic uncomplicated malaria controls by age and gender. Swain-Langley and McCoy blood group alleles were determined by restriction fragment length polymorphism and conditional logistic regression was carried out.

Results

No significant association was found between the African alleles and severe malaria-associated anaemia. However, children with Sl2/2 genotype were less likely to have cerebral malaria (OR = 0.17, 95% CI 0.04 to 0.72, P = 0.02) than children with Sl1/1. In particular, individuals with Sl2/2 McC a/b genotype were less likely to have cerebral malaria (OR = 0.18, 95% CI 0.04 to 0.77, P = 0.02) than individuals with Sl1/1 McC a/a .

Conclusion

These results support the hypothesis that the Sl2 allele and, possibly, the McC b allele evolved in the context of malaria transmission and that in certain combinations probably confer a survival advantage on these populations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Organization WH: World Health Report. 2002, Geneva, WHO Organization WH: World Health Report. 2002, Geneva, WHO
2.
go back to reference Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg. 2000, 94 Suppl 1: S1-90. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg. 2000, 94 Suppl 1: S1-90.
3.
go back to reference Rowe JA, Moulds JM, Newbold CI, Miller LH: P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature. 1997, 388: 292-295. 10.1038/40269.CrossRefPubMed Rowe JA, Moulds JM, Newbold CI, Miller LH: P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature. 1997, 388: 292-295. 10.1038/40269.CrossRefPubMed
4.
go back to reference Rowe JA, Rogerson SJ, Raza A, Moulds JM, Kazatchkine MD, Marsh K, Newbold CI, Atkinson JP, Miller LH: Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates. J Immunol. 2000, 165: 6341-6346.CrossRefPubMed Rowe JA, Rogerson SJ, Raza A, Moulds JM, Kazatchkine MD, Marsh K, Newbold CI, Atkinson JP, Miller LH: Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates. J Immunol. 2000, 165: 6341-6346.CrossRefPubMed
5.
go back to reference Waitumbi JN, Opollo MO, Muga RO, Misore AO, Stoute JA: Red cell surface changes and erythrophagocytosis in children with severe Plasmodium falciparum anemia. Blood. 2000, 95: 1481-1486.PubMed Waitumbi JN, Opollo MO, Muga RO, Misore AO, Stoute JA: Red cell surface changes and erythrophagocytosis in children with severe Plasmodium falciparum anemia. Blood. 2000, 95: 1481-1486.PubMed
6.
go back to reference Stoute JA, Odindo AO, Owuor BO, Mibei EK, Opollo MO, Waitumbi JN: Loss of red blood cell complement regulatory proteins and increased levels of circulating immune complexes are associated with severe malarial anemia. J Infect Dis. 2003, 187: 522-525. 10.1086/367712.CrossRefPubMed Stoute JA, Odindo AO, Owuor BO, Mibei EK, Opollo MO, Waitumbi JN: Loss of red blood cell complement regulatory proteins and increased levels of circulating immune complexes are associated with severe malarial anemia. J Infect Dis. 2003, 187: 522-525. 10.1086/367712.CrossRefPubMed
7.
go back to reference Waitumbi JN, Donvito B, Kisserli A, Cohen JH, Stoute JA: Age-related changes in red blood cell complement regulatory proteins and the susceptibility to severe malaria. J Infect Dis. 2004, 190: 1183-1191. 10.1086/423140.CrossRefPubMed Waitumbi JN, Donvito B, Kisserli A, Cohen JH, Stoute JA: Age-related changes in red blood cell complement regulatory proteins and the susceptibility to severe malaria. J Infect Dis. 2004, 190: 1183-1191. 10.1086/423140.CrossRefPubMed
8.
go back to reference Krych-Goldberg M, Atkinson JP: Structure-function relationships of complement receptor type 1. Immunol Rev. 2001, 180: 112-122. 10.1034/j.1600-065X.2001.1800110.x.CrossRefPubMed Krych-Goldberg M, Atkinson JP: Structure-function relationships of complement receptor type 1. Immunol Rev. 2001, 180: 112-122. 10.1034/j.1600-065X.2001.1800110.x.CrossRefPubMed
9.
go back to reference Ghiran I, Barbashov SF, Klickstein LB, Tas SW, Jensenius JC, Nicholson-Weller A: Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med. 2000, 192: 1797-1808. 10.1084/jem.192.12.1797.PubMedCentralCrossRefPubMed Ghiran I, Barbashov SF, Klickstein LB, Tas SW, Jensenius JC, Nicholson-Weller A: Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med. 2000, 192: 1797-1808. 10.1084/jem.192.12.1797.PubMedCentralCrossRefPubMed
10.
go back to reference Klickstein LB, Barbashov SF, Liu T, Jack RM, Nicholson-Weller A: Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity. 1997, 7: 345-355. 10.1016/S1074-7613(00)80356-8.CrossRefPubMed Klickstein LB, Barbashov SF, Liu T, Jack RM, Nicholson-Weller A: Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity. 1997, 7: 345-355. 10.1016/S1074-7613(00)80356-8.CrossRefPubMed
11.
go back to reference Carlson J, Helmby H, Hill AV, Brewster D, Greenwood BM, Wahlgren M: Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet. 1990, 336: 1457-1460. 10.1016/0140-6736(90)93174-N.CrossRefPubMed Carlson J, Helmby H, Hill AV, Brewster D, Greenwood BM, Wahlgren M: Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet. 1990, 336: 1457-1460. 10.1016/0140-6736(90)93174-N.CrossRefPubMed
12.
go back to reference Rowe A, Obeiro J, Newbold CI, Marsh K: Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun. 1995, 63: 2323-2326.PubMedCentralPubMed Rowe A, Obeiro J, Newbold CI, Marsh K: Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun. 1995, 63: 2323-2326.PubMedCentralPubMed
13.
go back to reference Ahearn JM, Fearon DT: Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv Immunol. 1989, 46: 183-219.CrossRefPubMed Ahearn JM, Fearon DT: Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv Immunol. 1989, 46: 183-219.CrossRefPubMed
14.
go back to reference Herrera AH, Xiang L, Martin SG, Lewis J, Wilson JG: Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin Immunol Immunopathol. 1998, 87: 176-183. 10.1006/clin.1998.4529.CrossRefPubMed Herrera AH, Xiang L, Martin SG, Lewis J, Wilson JG: Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin Immunol Immunopathol. 1998, 87: 176-183. 10.1006/clin.1998.4529.CrossRefPubMed
15.
go back to reference Rowe JA, Raza A, Diallo DA, Baby M, Poudiougo B, Coulibaly D, Cockburn IA, Middleton J, Lyke KE, Plowe CV, Doumbo OK, Moulds JM: Erythrocyte CR1 expression level does not correlate with a HindIII restriction fragment length polymorphism in Africans; implications for studies on malaria susceptibility. Genes Immun. 2002, 3: 497-500. 10.1038/sj.gene.6363899.CrossRefPubMed Rowe JA, Raza A, Diallo DA, Baby M, Poudiougo B, Coulibaly D, Cockburn IA, Middleton J, Lyke KE, Plowe CV, Doumbo OK, Moulds JM: Erythrocyte CR1 expression level does not correlate with a HindIII restriction fragment length polymorphism in Africans; implications for studies on malaria susceptibility. Genes Immun. 2002, 3: 497-500. 10.1038/sj.gene.6363899.CrossRefPubMed
16.
go back to reference Moulds JM, Nickells MW, Moulds JJ, Brown MC, Atkinson JP: The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-langley, and York blood group antisera. J Exp Med. 1991, 173: 1159-1163. 10.1084/jem.173.5.1159.CrossRefPubMed Moulds JM, Nickells MW, Moulds JJ, Brown MC, Atkinson JP: The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-langley, and York blood group antisera. J Exp Med. 1991, 173: 1159-1163. 10.1084/jem.173.5.1159.CrossRefPubMed
17.
go back to reference Moulds JM, Zimmerman PA, Doumbo OK, Kassambara L, Sagara I, Diallo DA, Atkinson JP, Krych-Goldberg M, Hauhart RE, Hourcade DE, McNamara DT, Birmingham DJ, Rowe JA, Moulds JJ, Miller LH: Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood. 2001, 97: 2879-2885. 10.1182/blood.V97.9.2879.CrossRefPubMed Moulds JM, Zimmerman PA, Doumbo OK, Kassambara L, Sagara I, Diallo DA, Atkinson JP, Krych-Goldberg M, Hauhart RE, Hourcade DE, McNamara DT, Birmingham DJ, Rowe JA, Moulds JJ, Miller LH: Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood. 2001, 97: 2879-2885. 10.1182/blood.V97.9.2879.CrossRefPubMed
18.
go back to reference Rao N, Ferguson DJ, Lee SF, Telen MJ: Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol. 1991, 146: 3502-3507.PubMed Rao N, Ferguson DJ, Lee SF, Telen MJ: Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol. 1991, 146: 3502-3507.PubMed
19.
go back to reference Daniels GL, Cartron JP, Fletcher A, Garratty G, Henry S, Jorgensen J, Judd WJ, Levene C, Lin M, Lomas-Francis C, Moulds JJ, Moulds JM, Moulds M, Overbeeke M, Reid ME, Rouger P, Scott M, Sistonen P, Smart E, Tani Y, Wendel S, Zelinski T: International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Vancouver Report. Vox Sang. 2003, 84: 244-247. 10.1046/j.1423-0410.2003.00282.x.CrossRefPubMed Daniels GL, Cartron JP, Fletcher A, Garratty G, Henry S, Jorgensen J, Judd WJ, Levene C, Lin M, Lomas-Francis C, Moulds JJ, Moulds JM, Moulds M, Overbeeke M, Reid ME, Rouger P, Scott M, Sistonen P, Smart E, Tani Y, Wendel S, Zelinski T: International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Vancouver Report. Vox Sang. 2003, 84: 244-247. 10.1046/j.1423-0410.2003.00282.x.CrossRefPubMed
20.
go back to reference Zimmerman PA, Fitness J, Moulds JM, McNamara DT, Kasehagen LJ, Rowe JA, Hill AV: CR1 Knops blood group alleles are not associated with severe malaria in the Gambia. Genes Immun. 2003, 4: 368-373. 10.1038/sj.gene.6363980.PubMedCentralCrossRefPubMed Zimmerman PA, Fitness J, Moulds JM, McNamara DT, Kasehagen LJ, Rowe JA, Hill AV: CR1 Knops blood group alleles are not associated with severe malaria in the Gambia. Genes Immun. 2003, 4: 368-373. 10.1038/sj.gene.6363980.PubMedCentralCrossRefPubMed
21.
go back to reference Marsh K, Snow RW: Malaria transmission and morbidity. Parassitologia. 1999, 41: 241-246.PubMed Marsh K, Snow RW: Malaria transmission and morbidity. Parassitologia. 1999, 41: 241-246.PubMed
22.
go back to reference Molyneux ME, Taylor TE, Wirima JJ, Borgstein A: Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med. 1989, 71: 441-459.PubMed Molyneux ME, Taylor TE, Wirima JJ, Borgstein A: Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med. 1989, 71: 441-459.PubMed
23.
go back to reference Farnert A, Arez AP, Correia AT, Bjorkman A, Snounou G, do Rosario V: Sampling and storage of blood and the detection of malaria parasites by polymerase chain reaction. Trans R Soc Trop Med Hyg. 1999, 93: 50-53. 10.1016/S0035-9203(99)90177-3.CrossRefPubMed Farnert A, Arez AP, Correia AT, Bjorkman A, Snounou G, do Rosario V: Sampling and storage of blood and the detection of malaria parasites by polymerase chain reaction. Trans R Soc Trop Med Hyg. 1999, 93: 50-53. 10.1016/S0035-9203(99)90177-3.CrossRefPubMed
24.
go back to reference Moulds JM, Thomas BJ, Doumbo O, Diallo DA, Lyke KE, Plowe CV, Rowe JA, Birmingham DJ: Identification of the Kna/Knb polymorphism and a method for Knops genotyping. Transfusion. 2004, 44: 164-169. 10.1111/j.1537-2995.2004.00615.x.PubMedCentralCrossRefPubMed Moulds JM, Thomas BJ, Doumbo O, Diallo DA, Lyke KE, Plowe CV, Rowe JA, Birmingham DJ: Identification of the Kna/Knb polymorphism and a method for Knops genotyping. Transfusion. 2004, 44: 164-169. 10.1111/j.1537-2995.2004.00615.x.PubMedCentralCrossRefPubMed
25.
go back to reference Paccaud JP, Carpentier JL, Schifferli JA: Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence. Eur J Immunol. 1990, 20: 283-289.CrossRefPubMed Paccaud JP, Carpentier JL, Schifferli JA: Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence. Eur J Immunol. 1990, 20: 283-289.CrossRefPubMed
26.
go back to reference Molina H, Holers VM, Li B, Fung Y, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Chaplin DD: Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci U S A. 1996, 93: 3357-3361. 10.1073/pnas.93.8.3357.PubMedCentralCrossRefPubMed Molina H, Holers VM, Li B, Fung Y, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Chaplin DD: Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci U S A. 1996, 93: 3357-3361. 10.1073/pnas.93.8.3357.PubMedCentralCrossRefPubMed
27.
go back to reference Cockburn IA, Mackinnon MJ, O'Donnell A, Allen SJ, Moulds JM, Baisor M, Bockarie M, Reeder JC, Rowe JA: A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc Natl Acad Sci U S A. 2004, 101: 272-277. 10.1073/pnas.0305306101.PubMedCentralCrossRefPubMed Cockburn IA, Mackinnon MJ, O'Donnell A, Allen SJ, Moulds JM, Baisor M, Bockarie M, Reeder JC, Rowe JA: A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc Natl Acad Sci U S A. 2004, 101: 272-277. 10.1073/pnas.0305306101.PubMedCentralCrossRefPubMed
Metadata
Title
Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya
Authors
Vandana Thathy
JoAnn M Moulds
Bernard Guyah
Walter Otieno
José A Stoute
Publication date
01-12-2005
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2005
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-4-54

Other articles of this Issue 1/2005

Malaria Journal 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine